Please assess the completion status of the following clinical trial:

Trial Title: Cervical Occlusion for the Prevention of Preterm Birth

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The physician in charge considered that a cerclage was indicated.~* Gestational age between 12 and 27 completed weeks.~* Previous late mid-trimester miscarriage, or spontaneous preterm labour and delivery before 28 weeks with or without previous cerclages.~* Previous cerclage because of short cervix.~* Confirmed gestational age defined as gestational age estimated by ultrasound at less than or equal to 22+0 weeks, and/or certain last menstrual period.~* Vaginal infection treated before cerclage.~* Ability to read and understand the relevant national language.~* Consent obtained in accordance with specifications of the local research ethics committee.~* 18 years or more of age and legally competent.~Exclusion Criteria:~* Demonstrated cervical infection.~* Obstetrical complications in the current pregnancy.~* Multiple pregnancies.~* History of a significant abruptio placenta in a previous pregnancy.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Therapeutic Trial (Type: EXPERIMENTAL): Therapeutic cervical cerclage with or without cervical occlusion in women presenting with short cervix (\<25mm)
- Prophylactic Trial (Type: EXPERIMENTAL): Prophylactic cervical cerclage with or without cervical occlusion in women with a history of cervical insufficiency

Based on this trial design, predict the completion outcome and termination type (if applicable).